Top stories in gastroenterology: Hemoclips may not reduce post-polypectomy bleeding, Entyvio superior to Humira - Healio

The top stories in gastroenterology last week were from Digestive Disease Week and included a study that found prophylactic placement of hemoclips following the removal of large colon polyps did not decrease the risk for post-polypectomy bleeding and results from the VARSITY study that showed clinical and endoscopic outcomes of Entyvio treatment were superior to those of Humira in moderately to severely active ulcerative colitis at 1 year.

Other highlights were findings that indicated patients at risk for non-alcoholic steatohepatitis are under-recognized in primary care, a study that found data collected from activity trackers can help predict elevated biomarkers of inflammation in inflammatory bowel disease and results from the ICON study that demonstrated fecal microbiota transplantation was safe and effective in patients with inflammatory bowel disease and Clostridioides difficile infection.

Hemoclips may not reduce post-polypectomy bleeding

SAN DIEGO — Prophylactic placement of hemoclips following the removal of large colon polyps did not decrease the risk for post-polypectomy bleeding, which questions the common practice of using hemoclips during polypectomy, according to the results of a prospective, randomized study presented at Digestive Disease Week. Read more.

VARSITY: Entyvio beats Humira in ulcerative colitis

SAN DIEGO – The VARSITY study results showed that clinical and endoscopic outcomes of Entyvio treatment were superior to those of Humira in moderately to severely active ulcerative colitis at 1 year, a speaker said. Read more.

Patients at risk for non-alcoholic steatohepatitis are under-recognized in primary care

SAN DIEGO – Patients at risk for non-alcoholic steatohepatitis may be “considerably under-recognized” in primary care, but the Non-Alcoholic Fatty Liver Disease Fibrosis Score is an effective tool for identifying these patients, according to a speaker. Read more.

Activity trackers help predict inflammatory bowel disease relapse

SAN DIEGO — Data collected from activity trackers like Fitbit can help predict elevated biomarkers of inflammation in inflammatory bowel disease, a speaker said. Read more.

Fecal microbiota transplantation safe, effective in patients with inflammatory bowel disease, C. diff infection

SAN DIEGO — Results from the ICON study presented at Digestive Disease Week demonstrated that fecal microbiota transplantation was safe and effective in patients with inflammatory bowel disease and Clostridioides difficile infection. Read more.

http://bit.ly/2JOGAh5